Poster Abstract Session:
254. Vaccines for the Elderly and Immune Compromised
Saturday, October 6, 2018: 12:30 PM-1:45 PM
Room: S Poster Hall

Tracks: Adult ID, Investigative ID


Presentations:
Pre-transplant Vaccination Adherence in Pediatric Solid Organ Transplant Patients at a Large Academic Medical Center
Eric Fela, PharmD; Kaitlyn Rivard, PharmD; Andrea Pallotta, PharmD; Michael Spinner, MA, PharmD; Maryjoy Lepak, PharmD; Blanca E Gonzalez, M.D
Circulating T follicular helper cells and immune response induced by influenza vaccine in children with acute lymphoblastic leukemia during maintenance therapy
Nicole Le Corre, MD/PhD; Constanza Martinez-Valdebenito, MS; Francisco Barriga, MD; Marcela Contreras, Nurse; Marcela Vidal, Nurse; Rosa Moreno, MD; Ximena Claverie, MD; Paula Contreras, Nurse; Lesly Huneman, Nurse; Tamara Garcia, PhD; Raveen Rathnasinghe, BS; Rafael Medina, PhD; Romina Alarcon, CLT; Marcela Ferres, MD, MPH
The Effectiveness of High-Dose Hepatitis B Vaccination in Patients Receiving Immunomodulatory Therapy
Murat Aydin, Assistant doctor; Firdevs Aksoy, Assistant Professor; Zehra Yildirim, nurse; Iftihar Koksal, Professor
Vaccination Rates in Post-Transplant Hematopoietic Stem Cell Transplant (HSCT) Patients: Where Do We Stand?
Hiba Ahmad, PharmD; Sarah Perreault, PharmD; Dayna McManus, PharmD, BCPS AQ-ID; Francine Foss, MD; Iris Isufi, MD; Stuart Seropian, MD; Jeffrey Topal, MD
The Impact of Reactogenicity after Administration of the Recombinant Zoster Vaccine upon the Physical Functioning and Quality of Life of Older Adults
Kenneth E. Schmader, MD; Myron J. Levin, MD; Katrijn Grupping, PhD; Sean Matthews, MSc; David Butuk, MD; Michael Chen, MD; Mohamed El Idrissi, MSc; Laurence A. Fissette, MSc; Charles Fogarty, MD; Paul Hartley, MD; Nicola P. Klein, MD, PhD; Max Nevarez, MD; Kari Uusinarkaus, MD; Lidia Oostvogels, MD; Desmond Curran, PhD
Posters
  • 2488_IDWeek_Schmader et al.pdf (650.4 kB)
  • CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™


    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.